Literature DB >> 6120408

Verapamil in Duchenne muscular dystrophy.

A E Emery, R Skinner, L C Howden, M B Matthews.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6120408     DOI： 10.1016/s0140-6736(82)92063-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Intravenous verapamil for tachyarrhythmia in Duchenne's muscular dystrophy.

Authors:  Y Ilan; M Hillman; R Oren
Journal:  Pediatr Cardiol       Date:  1990-07       Impact factor: 1.655

Review 2.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

3.  Early-Onset Late Gadolinium Enhancement is a Prognostic Factor for Duchenne Cardiomyopathy.

Authors:  Lorraine James; Jondavid Menteer; Lilith C Moss; Ramon Durazo-Arvizu; John C Wood; Leigh Ramos-Platt; Emmanuelle Tiongson; Jennifer A Su
Journal:  Pediatr Cardiol       Date:  2022-09-03       Impact factor: 1.838

4.  Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging.

Authors:  Wei Li; Wei Liu; Jia Zhong; Xin Yu
Journal:  J Cardiovasc Magn Reson       Date:  2009-10-22       Impact factor: 5.364

5.  Duchenne Muscular Dystrophy.

Authors:  Susan T. Iannaccone; Zohair Nanjiani
Journal:  Curr Treat Options Neurol       Date:  2001-03       Impact factor: 3.972

Review 6.  Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy.

Authors:  A R Burr; J D Molkentin
Journal:  Cell Death Differ       Date:  2015-06-19       Impact factor: 15.828

7.  Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy.

Authors:  Janelle M Spinazzola; Louis M Kunkel
Journal:  Expert Opin Orphan Drugs       Date:  2016-10-18       Impact factor: 0.694
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.